Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies

Shinohara, Mitsuru, Tachibana, Masaya, Kanekiyo, Takahisa, Bu, Guojun·2017·Journal of Lipid Research

Cited by (309)

Items 101–200 of 309

  1. Alzheimer's Disease: Many Failed Trials, So Where Do We Go from Here?
    Allison Bethanne Reiss, Amy D. Glass, Thomas Wısnıewskı, Benjamin L. Wolozin, Irving H. Gomolin, Aaron Pinkhasov, Joshua De Leon, Mark M. Stecker · 2020 · Journal of Investigative Medicine
  2. Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding
    Devaraj Venkatapura Chandrashekar, G. Chuli Roules, Nataraj Jagadeesan, Urvashi R. Panchal, Adenike Oyegbesan, Oghenetega E. Imiruaye, Hai Zhang, Jerome Garcia, Kamaljit Kaur, Sanda Win et al. · 2024 · Neurobiology of Disease
  3. Amyloid-β oligomers increase the binding and internalization of tau oligomers in human synapses
    Kadamangudi, Shrinath, Marcatti, Michela, Zhang, Wen-Ru, Fracassi, Anna, Kayed, Rakez, Limon, Agenor, Taglialatela, Giulio · 2024 · Acta Neuropathologica
  4. Exercise and the organ-brain axis: Regulation of neurological disorders by emerging exerkines
    Yan Dai, Xiaoke Dou, Bingqing Nie, Yan Sun, Pu Chen, Cuiying Fu, Xinyi Zhang, Yangqi Chu, Qianhao Gao, Yangyang Ge et al. · 2025 · Pharmacological Research
  5. The role of LRP1 in Aβ efflux transport across the blood-brain barrier and cognitive dysfunction in diabetes mellitus
    Xue Pan, Long Zz, Jiang Gg, Wang Lp, Bian Cm, Wang Yl, M.F. Chen, Wei Li · 2022 · Neurochemistry International
  6. Deconstructing the intercellular interactome in vascular dementia with focal ischemia for therapeutic applications
    Min Tian, Riki Kawaguchi, Yang Shen, Michał Machnicki, Nikole G. Villegas, Delaney R. Cooper, Natalia Montgomery, Ying Cai, Jacqueline Haring, Ruirui Lan et al. · 2025 · Cell
  7. Lipids and lipoproteins may play a role in the neuropathology of Alzheimer’s disease
    Ömer Akyol, Sümeyya Akyol, Mei‐Chuan Chou, Shioulan Chen, Ching‐Kuan Liu, Salih Selek, Jair C. Soares, Chu‐Huang Chen · 2023 · Frontiers in Neuroscience
  8. Recent insights into the functions and mechanisms of antisense RNA: emerging applications in cancer therapy and precision medicine
    Shahab Ur Rehman, Numan Ullah, Zhenbin Zhang, Yongkang Zhen, Aziz Ud-Din, Hengmi Cui, Mengzhi Wang · 2024 · Frontiers in Chemistry
  9. iPSC-derived blood-brain barrier modeling reveals APOE isoform-dependent interactions with amyloid beta
    Yunfeng Ding, Sean P. Palecek, Eric V. Shusta · 2024 · Fluids and Barriers of the CNS
  10. Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) as a Novel Regulator of Early Astroglial Differentiation
    Ramona Romeo, Damian Boden-El Mourabit, Anja Scheller, Melanie D. Mark, Andréas Faissner · 2021 · Frontiers in Cellular Neuroscience
  11. Peripheral apolipoprotein E proteins and their binding to LRP1 antagonize Alzheimer’s disease pathogenesis in the brain during peripheral chronic inflammation
    Hana Na, Jack B. Yang, Zhengrong Zhang, Qini Gan, Hua Tian, Ibraheem M. Rajab, Lawrence A. Potempa, Qiushan Tao, Wei Qiao Qiu · 2023 · Neurobiology of Aging
  12. Pathology of Amyloid-β (Aβ) Peptide Peripheral Clearance in Alzheimer’s Disease
    Andrey Tsoy, Bauyrzhan A. Umbayev, Aliya Kassenova, Bibifatima Kaupbayeva, Sholpan Askarova · 2024 · International Journal of Molecular Sciences
  13. Haploinsufficiency of microglial MyD88 ameliorates Alzheimer's pathology and vascular disorders in APP / PS1 ‐transgenic mice
    Wenqiang Quan, Qinghua Luo, Wenlin Hao, Inge Tomic, Tomomi Furihata, Walter Schulz‐Schaeffer, Michael Dieter Menger, Klaus C Fassbender, Yang Liu · 2021 · Glia
  14. Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
    Weimin Qiu, Hui Liu, Yijun Liu, Xin Lü, Lei Wang, Yanyu Hu, Feng Feng, Qi Li, Haopeng Sun · 2023 · Medicinal Research Reviews
  15. In Silico Interactions of Natural and Synthetic Compounds with Key Proteins Involved in Alzheimer’s Disease: Prospects for Designing New Therapeutics Compound
    Mehran Ebrahimi Shah-abadi, Armin Ariaei, Fatemeh Moradi, Auob Rustamzadeh, Rastegar Rahmani Tanha, Nader Sadigh, Mohsen Marzban, Mahdi Heydari, Vahid Tavakolian Ferdousie · 2023 · Neurotoxicity Research
  16. Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease
    Niya Wang, Xiang Yang, Zhong Zhao, Da Liu, Xiaoyan Wang, Hao Tang, Chuyu Zhong, Xinzhang Chen, Wenli Kelly Chen, Qiang Meng · 2023 · Frontiers in Molecular Neuroscience
  17. Alzheimer’s disease transcriptional landscape in ex vivo human microglia
    Roman Kosoy, John F. Fullard, Jaroslav M. Bendl, Steven P. Kleopoulos, Zhiping Shao, Stathis Argyriou, Deepika Dayal Mathur, Konstantina Psychogyiou, Periklis Malakates, James M. Vicari et al. · 2025 · Nature Neuroscience
  18. Revelation of Pivotal Genes Pertinent to Alzheimer’s Pathogenesis: A Methodical Evaluation of 32 GEO Datasets
    G. N. S. Hema Sree, Saraswathy Ganesan Rajalekshmi, Raghunadha Reddy Burri · 2021 · Journal of Molecular Neuroscience
  19. The potential anti-Alzheimer's activity of Oxalis corniculata Linn. Methanolic extract in experimental rats: Role of APOE4/LRP1, TLR4/NF-κβ/NLRP3, Wnt 3/β-catenin/GSK-3β, autophagy and apoptotic cues
    Karema Abu‐Elfotuh, Ahmed M. Hamdan, Shaza A. Mohamed, Riham Omar Bakr, Amal Hussein Ahmed, Ahmed M. Atwa, Amira M. Hamdan, Ahad Ghanem Alanzai, Raghad Khalid Alnahhas, Ayah M. H. Gowifel et al. · 2024 · Journal of Ethnopharmacology
  20. Current Perspectives and Mechanisms of Relationship between Intestinal Microbiota Dysfunction and Dementia: A Review
    Menizibeya Osain Welcome · 2018 · Dementia and Geriatric Cognitive Disorders Extra
  21. Microglia pack a toolbox for life
    Zengeler, Kristine E., Lukens, John R. · 2024 · Trends in Immunology
  22. Cortical lipid metabolic pathway alteration of early Alzheimer’s disease and candidate drugs screen
    Linshuang Wang, Fengxue Qu, Xueyun Yu, Sixia Yang, Binbin Zhao, Yaojing Chen, P. Li, Zhanjun Zhang, Junying Zhang, Xuejie Han et al. · 2024 · European journal of medical research
  23. A genome-wide screen for human salicylic acid (SA)-binding proteins reveals targets through which SA may influence development of various diseases
    Hyong Woo Choi, Lei Wang, Adrian F. Powell, Susan R. Strickler, Dekai Wang, D’Maris Amick Dempsey, Frank C. Schroeder, Daniel F. Klessig · 2019 · Scientific Reports
  24. Therapeutic Potential of Direct Clearance of the Amyloid-β in Alzheimer’s Disease
    Dong‐Eun Kim, Ronny Priefer · 2020 · Brain Sciences
  25. Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools
    Ayon Bhattacharya, Rani Ashouri, Madison Fangman, Alexandra Mazur, Timothy Garett, Sylvain Doré · 2021 · International Journal of Molecular Sciences
  26. Targeting Ferroptosis/Nrf2 Pathway Ameliorates AlCl3-Induced Alzheimer’s Disease in Rats: Neuroprotective Effect of Morin Hydrate, Zeolite Clinoptilolite, and Physical Plus Mental Activities
    Karema Abu‐Elfotuh, Yasmin Mahran, Walaa Bayoumie El Gazzar, Heba S. Youssef, Ahmed M. Hamdan, Tariq Mohammed Albalawi, Maha Alsunbul, Reem A. Alqahtani, Asmaa A. Mohammed · 2025 · International Journal of Molecular Sciences
  27. Low-density lipoprotein receptor-related protein-1 (LRP1) in the glial lineage modulates neuronal excitability
    Andréas Faissner · 2023 · Frontiers in Network Physiology
  28. Bone Marrow‐Derived GCA+ Immune Cells Drive Alzheimer's Disease Progression
    Rui Zhou, Liwen Wang, Lingyun Chen, Feng Xu, Ruoyu Zhou, Xiang Fang Peng, Jie Wen, Yan Huang, Haiyan Zhou · 2023 · Advanced Science
  29. Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases
    Puwen Chen, Fangsheng Wang, Baodian Ling, Yifan Zhu, Haihong Lin, Junyun Huang, Xiao-Ling Wang · 2025 · International Journal of Nanomedicine
  30. Transplantation of the LRP1high subpopulation of human umbilical cord-derived mesenchymal stem cells improves ovarian function in mice with premature ovarian failure and aged mice
    Jiacheng Shen, Li Wu, Xiaoying Shi, Gang Chen, Tingwei Liu, Fangfang Xu, Xiaocui Xu, Xiaochen Kou, Yanhong Zhao, Hong Wang et al. · 2024 · Stem Cell Research & Therapy
  31. Inflammatory Cytokine IL-1β Downregulates Endothelial LRP1 via MicroRNA-mediated Gene Silencing
    Heng-Wei Hsu, Carlos J. Rodríguez‐Ortiz, Joannee Zumkehr, Masashi Kitazawa · 2020 · Neuroscience
  32. Missing lnc(RNAs) in Alzheimer’s Disease?
    Rafaela Policarpo, Constantin van Outryve d’Ydewalle · 2021 · Genes
  33. Lipidopathy disrupts peripheral and central amyloid clearance in Alzheimer's disease: Where are our knowledge
    Shahram Darabi, Enam Alhagh Charkhat Gorgich, Fatemeh Moradi, Auob Rustamzadeh · 2025 · IBRO Neuroscience Reports
  34. Low‐Density Lipoprotein Receptor‐Related Protein 6 Cell Surface Availability Regulates Fuel Metabolism in Astrocytes
    Hei‐Man Chow, Jacquelyne Ka‐Li Sun, Ronald P. Hart, Kenneth K.Y. Cheng, Clara Hiu-Ling Hung, Tsun Ming Lau, Kin Ming Kwan · 2021 · Advanced Science
  35. A 3D human iPSC-derived multi-cell type neurosphere system to model cellular responses to chronic amyloidosis
    Stefan Wendt, Ada J. Lin, Sarah N. Ebert, Declan J. Brennan, Wenji Cai, Yanyang Bai, Da Young Kong, Stefano Sorrentino, Christopher J. Groten, Christopher Lee et al. · 2025 · Journal of Neuroinflammation
  36. Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
    Julia Y. Ljubimova, Arshia Ramesh, Liron Limor Israel, Eggehard Holler · 2021 · Nanomaterials
  37. New insight into the role of altered brain cholesterol metabolism in the pathogenesis of AD: A unifying cholesterol hypothesis and new therapeutic approach for AD
    Xiaobo Yang, Kai Yao, Mengqi Zhang, Wenbin Zhang, Hengbing Zu · 2025 · Brain Research Bulletin
  38. LRP4-related signalling pathways and their regulatory role in neurological diseases
    Baihui Chen, Ze-Yu Lin, Xiao-Xue Zeng, Yihan Jiang, Fei Geng · 2023 · Brain Research
  39. Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease
    Michael Okafor, Peter Faller, Nicolas Vitale · 2025 · Translational Neurodegeneration
  40. Molecular Heterogeneity of the Brain Endothelium
    Nada Alnaqbi, Mohammad G. Mohammad, Rifat Hamoudi, Aloïse M Mabondzo, Rania Harati · 2023 · Current Issues in Molecular Biology
  41. Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
    Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, Keith A. Webster, Lina A. Shehadeh · 2023 · Biomedicines
  42. Sequence of Molecular Events in the Development of Alzheimer’s Disease: Cascade Interactions from Beta-Amyloid to Other Involved Proteins
    Soghra Bagheri, Ali Akbar Saboury, Luciano Saso · 2024 · Cells
  43. Potential mechanisms of non-coding RNA regulation in Alzheimer’s disease
    Yue Sun, Xinping Pang, Xudong Huang, Dinglu Liu, Jingyue Huang, Pengtao Zheng, Yanyu Wei, Chao-Yang Pang · 2024 · Neural Regeneration Research
  44. Curious Dichotomies of Apolipoprotein E Function in Alzheimer’s Disease and Cancer—One Explanatory Mechanism of Inverse Disease Associations?
    Perks, Claire M., Barker, Rachel M., Alhadrami, Mai, Alkahtani, Omar, Gill, Emily, Grishaw, Mary, Harland, Abigail J., Henley, Peter, Li, Haonan, O’Sullivan, Ellie et al. · 2025 · Genes
  45. Unraveling the Role of LRP1 in Alzheimer’s Disease: A Focus on Aβ Clearance and the Liver-Brain Axis
    Wanyue Yang, Zilin Wei, Tianhui Wang · 2025 · Journal of Molecular Neuroscience
  46. Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
    Lauren Owens, Alexandre Benedetto, Neil Dawson, Christopher J. Gaffney, Edward T. Parkin · 2021 · Brain Research
  47. Exploring new avenues for modifying course of progression of Alzheimer's disease: The rise of natural medicine
    Sarah Lye, Caitlin E. Aust, Lyn Robyn Griffiths, Francesca Fernandez · 2021 · Journal of the Neurological Sciences
  48. Synthesis and Characterization of Salinomycin-Loaded High-Density Lipoprotein and Its Effects on Cervical Cancer Cells and Cervical Cancer Stem Cells
    Xirui Yin, Yuhui Lu, Miao Zou, Liuli Wang, Xuan Zhou, Yingyu Zhang, Manman Su · 2021 · International Journal of Nanomedicine
  49. LRP-1 receptor combines EGFR signalling and eHsp90α autocrine to support constitutive breast cancer cell motility in absence of blood supply
    Cheng Chang, Xin Tang, Daniel Mosallaei, Mei Chen, David T. Woodley, Axel H. Schönthal, Wei Li · 2022 · Scientific Reports
  50. Lipolysis-Stimulated Lipoprotein Receptor Acts as Sensor to Regulate ApoE Release in Astrocytes
    Améziane Herzine, Ghita Sekkat, Sandra Kaminski, Gaetano Calcagno, Sandrine Boschi‐Müller, Héla Safi, Catherine Corbier, Sophie Visvikis‐Siest, Thomas Claudepierre, Frances T. Yen · 2022 · International Journal of Molecular Sciences
  51. The protective role of hippocampal LRP1 knockdown involves synaptic plasticity through the promoting microtubule dynamics and activation of Akt/GSK-3β pathway in depressive rats
    Hui Wang, Liang Liang, Can Yang, Ling Xiao, Huiling Wang, Gaohua Wang, Zhixian Zhu · 2022 · Journal of Affective Disorders
  52. Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
    David A. Loeffler · 2024 · Journal of Alzheimer s Disease
  53. Rare, pathogenic variants in LRP10 are associated with amyotrophic lateral sclerosis in patients from mainland China
    Jie Ni, Zhen Liu, Wanzhen Li, Yanchun Yuan, Ling Huang, Yiting Hu, Pan Liu, Xiaorong Hou, Bin Jiao, Jinchen Li et al. · 2020 · Neurobiology of Aging
  54. Effects of Fish Oil Combined with Selenium and Zinc on Learning and Memory Impairment in Aging Mice and Amyloid Precursor Protein Processing
    Chao-xu Fu, Lin Dai, Xiu-yuan Yuan, Yanji Xu · 2020 · Biological Trace Element Research
  55. LRP1 at the crossroads of Aβ clearance and therapeutic targeting in Alzheimer’s disease
    Yuepeng Deng, Haolin Yin, Zihao Lu, Huan Lan, Wenxiong Liu, Chao Zuo, Nanfang Pan, Xiaohe Tian, Q. Gong · 2026 · Frontiers in Aging Neuroscience
  56. Association of Low-Density Lipoprotein Receptor-Related Protein 1 and Its rs1799986 Polymorphism With Mild Cognitive Impairment in Chinese Patients With Type 2 Diabetes
    Wuyou Cao, Sai Tian, Haoqiang Zhang, Wenwen Zhu, Ke An, Jijing Shi, Yang Yuan, Shaohua Wang · 2020 · Frontiers in Neuroscience
  57. MAD—microbial (origin of) Alzheimer’s disease hypothesis: from infection and the antimicrobial response to disruption of key copper-based systems
    Jin-Hong Min, Heela Sarlus, Robert Adam Harris · 2024 · Frontiers in Neuroscience
  58. An endophenotype network strategy uncovers YangXue QingNao Wan suppresses Aβ deposition, improves mitochondrial dysfunction and glucose metabolism
    Xue Wang, Jinna Yang, Xiaolian Zhang, Jinyong Cai, Jieqi Zhang, Chuipu Cai, Yue Zhuo, Shuhuan Fang, Xinxin Xu, Hui Wang et al. · 2024 · Phytomedicine
  59. Comprehensive characterization of the RNA editing landscape in the human aging brains with Alzheimer's disease
    Amit Kumar Gupta, William Martin, Andrew A. Pieper, Yinsheng Wang, Andrew J. Saykin, Feixiong Cheng · 2025 · Alzheimer s & Dementia
  60. Palmitoylated Prolactin-releasing Peptide Reduced Aβ Plaques and Microgliosis in the Cerebellum: APP/PS1 Mice Study
    Anna Mengr, Lucie Hrubá, Aneta Exnerová, Martina Holubová, Andrea Popelová, Blanka Železná, Jaroslav Kuneš, Lenka Maletı́nská · 2021 · Current Alzheimer Research
  61. Serum Glycoproteomics and Identification of Potential Mechanisms Underlying Alzheimer’s Disease
    Naphatthakarn Kerdsaeng, Sittiruk Roytrakul, Suwannee Chanprasertyothin, Piangporn Charernwat, Sirintorn Chansirikarnjana, Piyamitr Sritara, Jintana Sirivarasai · 2021 · Behavioural Neurology
  62. LRP1 regulates food intake and energy balance in GABAergic neurons independently of leptin action
    Min‐Cheol Kang, Ji A Seo, Hyon Lee, Aykut Göktürk Üner, Won‐Mo Yang, Kellen Cristina da Cruz Rodrigues, Hyun Jeong Kim, Wendy S. Li, John N. Campbell, Yossi Dagon et al. · 2020 · American Journal of Physiology-Endocrinology and Metabolism
  63. Triggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis
    Pierre-Alexandre Piec, Vincent Pons, Serge Rivest · 2021 · Cells
  64. Endocrine Regulation of Microvascular Receptor—Mediated Transcytosis and Its Therapeutic Opportunities: Insights by PCSK9—Mediated Regulation
    Mazura, Alexander D., Pietrzik, Claus U. · 2023 · Pharmaceutics
  65. Alzheimer's disease brain endothelial-like cells reveal differential drug transporter expression and modulation by potentially therapeutic focused ultrasound
    Juliana C.S. Chaves, Joanna Marta Wasielewska, Carla Cuní‐López, Laura M. Rantanen, Serine Lee, Jari Koıstınaho, Anthony Robert White, Lotta E. Oikari · 2023 · Neurotherapeutics
  66. Does glial lipid dysregulation alter sleep in Alzheimer’s and Parkinson’s disease?
    Lindsey D. Goodman, Matthew J. Moulton, Guang Lin, Hugo Jozef Bellen · 2024 · Trends in Molecular Medicine
  67. LRP1 mitigates intervertebral disc degeneration by inhibiting endoplasmic reticulum stress through stabilizing the PPARγ
    Dengbo Yao, Ming Li, Weike Zeng, Kun Wang, Zhuangyao Liao, Enming Chen, Tong Xing, Yuwei Liang, Jun Tang, Guoming Wen et al. · 2025 · Journal of Orthopaedic Translation
  68. Sex- and age- differences in the expression of critical blood-brain barrier regulators: a physiological context
    Xue Mi, Zi-Ling Ye, Xujun Zhang, Xiaochun Chen, Xiaoman Dai · 2025 · Biology of Sex Differences
  69. Neuronal ApoE Regulates the Cell-to-Cell Transmission of α-Synuclein
    Seo‐Jun Kang, Soo‐Jeong Kim, Hye Rin Noh, Beom Jin Kim, Jae-Bong Kim, Uram Jin, Sun Ah Park, Sang Myun Park · 2022 · International Journal of Molecular Sciences
  70. Unraveling the tau puzzle: a review of mechanistic targets and therapeutic interventions to prevent tau pathology in Alzheimer’s disease
    Sachin V Kammula, Sulagna Tripathi, Ning Wang, Valina Lynn Dawson, Ted M. Dawson, Xiaobo Mao · 2023 · Ageing and Neurodegenerative Diseases
  71. DKK3-LRP1 complex and a chemical inhibitor regulate Aβ clearance in models of Alzheimer’s disease
    Ruihan Yang, Lin Wang, Yue Li, Jian Zhu, Juxian Wang, David Schlessinger, Jian Sima · 2025 · Science Advances
  72. Calpain Inhibitor Calpeptin Improves Alzheimer’s Disease–Like Cognitive Impairments and Pathologies in a Diabetes Mellitus Rat Model
    Min Li, Siqi Zhou, Gege Wang, Luyao Qiao, Shouqin Yi, Tianpei Li, Xin Pan, Xu Liu, Zhenyu Tang · 2022 · Neurotoxicity Research
  73. Reappraisal of FDA approved drugs against Alzheimer’s disease based on differential gene expression and protein interaction network analysis: an in silico approach
    Hema Sree G N S, Saraswathy Ganesan Rajalekshmi, Manikanta Murahari, Raghunadha Reddy Burri · 2019 · Journal of Biomolecular Structure and Dynamics
  74. Blockade of brain alkaline phosphatase efficiently reduces amyloid-β plaque burden and associated cognitive impairment
    Lucia Soria-Tobar, L. Román-Valero, Á. Sebastián-Serrano, P. Aivar, Beatriz Álvarez-Castelao, Miguel Díaz-Hernández · 2024 · Alzheimer's Research & Therapy
  75. Inhibition of Acyl‐CoenzymeA: Cholesterol Acyltransferase 1 promotes shedding of soluble triggering receptor on myeloid cells 2 (TREM2) and low‐density lipoprotein receptor 1 (LRP1)‐dependent phagocytosis of amyloid beta protein in microglia
    Moriah J. Hovde, Anna Maaser‐Hecker, Jun‐Seok Bae, Rudolph E. Tanzi · 2025 · Alzheimer s & Dementia
  76. Exploration of plasma biomarkers for Alzheimer’s disease by targeted lipid metabolomics based on nuclear magnetic resonance (NMR) spectroscopy
    Qiao Su, Qinghe Liu, Bao‐Zhu Li, Zhonghui Ma, Fengfeng Bai, Yanzhe Li, Xuexin Yu, Meijuan Li, Jie Li, Daliang Sun · 2024 · Journal of Neural Transmission
  77. Unraveling APOE4: The dual role in CNS and peripheral inflammation in Alzheimer's disease
    Xiaohan Li, Zekun Li, Hua Chen, Hongmin Guo, Yihao Ge, Fang Dong, Fan Zhang, Feng Zhang · 2025 · International Immunopharmacology
  78. Nanobody Therapeutics in Alzheimer’s Disease: From Molecular Mechanisms to Translational Approaches
    Deepika Godugu, Kranthi Gattu, Parul Suri, Abel B. Daartey, Krishna Jadhav, Satish V. Rojekar · 2025 · Antibodies
  79. LRP1: a novel receptor for the transmission of pathological α-Synuclein
    Crystal Pan, Chao Peng · 2022 · Molecular Neurodegeneration
  80. Alzheimer’s Disease as a Membrane Dysfunction Tauopathy? New Insights into the Amyloid Cascade Hypothesis
    Tomáš Olejár, Nikol Jankovská, Radoslav Matěj · 2024 · International Journal of Molecular Sciences
  81. Metabolic Profile of Alzheimer’s Disease: Is 10-Hydroxy-2-decenoic Acid a Pertinent Metabolic Adjuster?
    Yuan Gong, Hongjie Luo, Zeju Li, Yijun Feng, Zhen Liu, Jie Chang · 2023 · Metabolites
  82. Potential Link Between Proprotein Convertase Subtilisin/Kexin Type 9 and Alzheimer’s Disease
    Oldham CE, Dayami Lopez · 2018 · International Journal of Biomedical Investigation
  83. PCSK9 Regulation of Lipid Metabolism in the Nervous System: Implications for Schwann Cell Function and Peripheral Neuropathy
    Agnieszka Nowacka, Maciej Śniegocki, Ewa Ziółkowska · 2025 · Cells
  84. Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition
    Kyle J. Connolly, Juliette Margaria, Erika Di Biase, Oliver Cooper, Penelope J. Hallett, Ole Isacson A · 2023 · Cells
  85. Apolipoprotein E isoforms and their Cys‐thiol modifications impact LRP1 ‐mediated metabolism of triglyceride‐rich lipoproteins
    Hiroto Matsuura, Shogo Akahane, Takahiro Kaido, Tomu Kamijo, Kenta Sakamoto, Kazuyoshi Yamauchi · 2024 · FEBS Letters
  86. Potential molecular mechanisms of tobacco smoke exposure in Alzheimer’s disease
    Yunqi Xie, Mingxue Yang, Haochen Wang, Yuting Chen, Xiaobo Shi, Huanwen Tang, Qian Sun · 2024 · Brain Research
  87. Helicobacter pylori-Vacuolating Cytotoxin A Induces Neurotoxic Neuroinflammation in Human Multicellular Models
    Van Thi Ai Tran, Niloofar Etemadi, Minh Tran, Jungmi Lee, Han Seok Ko, Dong‐Gyu Jo, Luke P. Lee, Hansang Cho · 2025 · BioChip Journal
  88. Differential impact of body mass index and leptin on baseline and longitudinal positron emission tomography measurements of the cerebral metabolic rate for glucose in amnestic mild cognitive impairment
    Christopher M. Weise, Kewei Chen, Yinghua Chen, Vivek Devadas, Yi Su, Eric M. Reiman · 2022 · Frontiers in Aging Neuroscience
  89. Detecting Biomarkers of Alzheimer’s Disease Based on Multi-constrained Uncertainty-Aware Adaptive Sparse Multi-view Canonical Correlation Analysis
    Wenbo Wang, Wei Kong, Shuaiqun Wang, Kai Wei · 2022 · Journal of Molecular Neuroscience
  90. Astrocytic-supplied cholesterol drives synaptic gene expression programs in developing neurons and downstream astrocytic transcriptional programs
    Emilia Vartiainen, Dhara Liyanage, Illinca Mazureac, Rachel A. Battaglia, Matthew Tegtmeyer, He Jax Xu, Noora Räsänen, Julia Sealock, Steven A. McCarroll, Ralda Nehme et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  91. Targeting A2M-LRP1 reverses uterine spiral artery remodeling disorder and alleviates the progression of preeclampsia
    Zhengrui Huang, Ping Zhang, Ruiping Chen, Lu Zhe Sun, Jingyun Wang, Ruiling Yan, Mengyuan Liu, Yuzhen Ding, Jian Wang, Jiachun Wei et al. · 2025 · Cell Communication and Signaling
  92. Exploring LRP-1 in the liver-brain axis: implications for Alzheimer’s disease
    Vivek Sharma · 2025 · Molecular Biology Reports
  93. Direct and indirect role of non-coding RNAs in company with amyloid and tau protein in promoting neuroinflammation in post-ischemic brain neurodegeneration
    Ryszard M. Pluta · 2025 · Frontiers in Cellular Neuroscience
  94. Targeting the HDAC4-NHE6-endosomal pH axis restores amyloid-β clearance and cognitive function in Alzheimer's disease mice
    Ningning Huang, Rui Hong, Xiaoyu Cui, Lijun Cao, Li Shi, Bin Chen, Yixuan Su, Xinru Xu, Chen Hua, Tao Ying · 2026 · Journal of Nanobiotechnology
  95. A Comprehensive Review on Potential Molecular Drug Targets for the Management of Alzheimer's Disease
    Chanchal Sharma, Avijit Mazumder · 2024 · Central Nervous System Agents in Medicinal Chemistry
  96. An investigation into DNA methylation patterns associated with risk preference in older individuals
    Laura Jane Smyth, Sharon Mary Cruise, Jianjun Tang, Ian Stuart Young, Bernadette McGuinness, Frank Kee, Amy Jayne McKnight · 2021 · Epigenetics
  97. Counteracting health risks by Modulating Homeostatic Signaling
    Junqiang J. Tian, Mark A. Levy, Xuekai Zhang, Robert Sinnott, Rolando Lorenzo Maddela · 2022 · Pharmacological Research
  98. Soluble LRP-1 in Parkinson’s disease: clues for paradoxical effects
    Betül Özdilek, Mehmet Ali Ağırbaşlı · 2022 · International Journal of Neuroscience
  99. Defining the altered glycoproteomic space of the early secretory pathway by class I mannosidase pharmacological inhibition
    Cristian V. A. Munteanu, Gabriela N. Chirițoiu, Andrei‐José Petrescu, Stefana Maria Petrescu · 2023 · Frontiers in Molecular Biosciences
  100. Unbiased Classification of the Human Brain Proteome Resolves Distinct Clinical and Pathophysiological Subtypes of Cognitive Impairment
    Lenora A. Higginbotham, Kathleen Carter, Eric B. Dammer, Rafi U. Haque, Erik C. B. Johnson, Duc M. Duong, Luming Yin, Philip L. De Jager, David Alan Bennett, James J. Lah et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)